Building a future where no one dies from skin cancer.

Skin Analytics delivers world-leading skin cancer pathways through our clinically proven AI technology.

We partner with health systems to improve diagnostic capacity and ensure every patient receives the right care at the right time

Trusted by our partners

Optimize Clinician Capacity

Our AI reduces unnecessary referrals, freeing up vital GP time and easing the long-term pressure on secondary care.

Improve Patient Access

Ensure equitable care across every region. Provide rapid, expert-level dermatological assessments to all patients, regardless of local specialist availability or geography.

Sustainability: Future-Proofing the Pathway

Move beyond short-term fixes toward a scalable, tech-enabled model.

DERM Pathway:

The world’s only Class III CE-marked AI for skin cancer.

lesions assessed as ‘high-risk’ by DERM are:

20-40%

patients typically discharged

47%

increase in dermatologist-reviewed cases confirmed as malignant

2x

more likely to be routed to biopsy or excision

DERM Performance

DERM performs at least as well as a face-to-face dermatologist.

99.8%

Dermatologist

99.9%

DERM

Negative Predictive Value (Melanoma)

Interested?

Contact our team to find out more